Home » Topics » Regulatory » Patents

Patents
RSS

Neurogen compounds interacting with CRF1 receptors for stress-related disorders

Oct. 1, 1998

BASF patents new series with endothelin-antagonist activity

Oct. 1, 1998

Novel erythromycins from HMR useful for Gram-positive and other infections

Oct. 1, 1998

Piperazines as inhibitors of MMPs and/or TNF-alpha prepared at Fujisawa

Oct. 1, 1998

Yamanouchi and Merck KGaA work together to develop Na+/H+ exchange inhibitors

Sep. 30, 1998

Pyrrole antiviral agents prepared and evaluated at Rhone-Poulenc Rorer

Sep. 30, 1998

Dual LTD4 antagonists/histamine release inhibitors in development at Daiichi

Sep. 30, 1998

Antisecretory benzodiazepines for GI disorders designed at Zeria

Sep. 30, 1998

Sanofi describes new series acting on vasopressin and/or oxytocin receptors

Sep. 30, 1998

Peptide analgesics described by Asahi Glass

Sep. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...